| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study. | Br J Cancer | 2011 | 0.96 |
| 2 | Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma. | Ecancermedicalscience | 2008 | 0.75 |
| 3 | Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration. | Ann Oncol | 2009 | 0.75 |
| 4 | Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination. | Chemotherapy | 2011 | 0.75 |
| 5 | A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma. | Acta Oncol | 2010 | 0.75 |
| 6 | The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory study. | Psychooncology | 2013 | 0.75 |